Posted by Netch on July 21, 2009, at 7:22:36
In reply to Re: Novartis is delaying Agomelatine in the US » Netch, posted by Phillipa on July 20, 2009, at 11:49:18
> Any idea why since it's now in Europe? Were there problems? Phillipa
Sorry, no idea. Agomelatine may affect liver and raise AST and ALT levels. This side effect is known and all patients will be tested during the first 24 weeks.
poster:Netch
thread:907618
URL: http://www.dr-bob.org/babble/20090721/msgs/907718.html